Literature DB >> 11226362

Development of the health and economic consequences of smoking interactive model.

M E Orme1, S L Hogue, L M Kennedy, A C Paine, C Godfrey.   

Abstract

OBJECTIVE: To describe the health and economic consequences of smoking model, a user friendly, web based tool, designed to estimate the health and economic outcomes associated with smoking and the benefits of smoking cessation.
RESULTS: An overview of the development of the model equations and user interface is given, and data from the UK are presented as an example of the model outputs. These results show that a typical smoking cessation strategy costs approximately 1200 pounds sterling per life year saved and 22,000 pounds sterling per death averted.
CONCLUSIONS: The model successfully captures the complexity required to model smoking behaviour and associated mortality, morbidity, and health care costs. Furthermore, the interface provides the results in a simple and flexible way so as to be useful to a variety of audiences and to simulate a variety of smoking cessation methods.

Mesh:

Year:  2001        PMID: 11226362      PMCID: PMC1763982          DOI: 10.1136/tc.10.1.55

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  21 in total

1.  The health care costs of smoking.

Authors:  J J Barendregt; L Bonneux; P J van der Maas
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

2.  Quantifying the disease impact of cigarette smoking with SAMMEC II software.

Authors:  J M Shultz; T E Novotny; D P Rice
Journal:  Public Health Rep       Date:  1991 May-Jun       Impact factor: 2.792

3.  State estimates of Medicaid expenditures attributable to cigarette smoking, fiscal year 1993.

Authors:  L S Miller; X Zhang; T Novotny; D P Rice; W Max
Journal:  Public Health Rep       Date:  1998 Mar-Apr       Impact factor: 2.792

Review 4.  Smoking cessation: evidence based recommendations for the healthcare system.

Authors:  M Raw; A McNeill; R West
Journal:  BMJ       Date:  1999-01-16

5.  The health care costs of smoking.

Authors:  D Heaney
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

6.  The health care costs of smoking.

Authors:  T A Hodgson
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

7.  The health care costs of smoking.

Authors:  J F Fries
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

Review 8.  Clinical economics. A guide to the economic analysis of clinical practices.

Authors:  J M Eisenberg
Journal:  JAMA       Date:  1989-11-24       Impact factor: 56.272

9.  Five-hundred life-saving interventions and their cost-effectiveness.

Authors:  T O Tengs; M E Adams; J S Pliskin; D G Safran; J E Siegel; M C Weinstein; J D Graham
Journal:  Risk Anal       Date:  1995-06       Impact factor: 4.000

10.  Tobacco--the growing epidemic.

Authors:  R Peto; Z M Chen; J Boreham
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

View more
  16 in total

1.  Simulation modeling and tobacco control: creating more robust public health policies.

Authors:  David T Levy; Joseph E Bauer; Hye-Ryeon Lee
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

Review 2.  Economic evaluation of smoking-cessation therapies: a critical and systematic review of simulation models.

Authors:  Kristian Bolin
Journal:  Pharmacoeconomics       Date:  2012-07-01       Impact factor: 4.981

3.  The role of public policies in reducing smoking prevalence in California: results from the California tobacco policy simulation model.

Authors:  David T Levy; Andrew Hyland; Cheryl Higbee; Lillian Remer; Christine Compton
Journal:  Health Policy       Date:  2006-10-19       Impact factor: 2.980

4.  Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan.

Authors:  Ataru Igarashi; Hiroki Takuma; Takashi Fukuda; Kiichiro Tsutani
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

5.  Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Authors:  Lieven Annemans; Kristiaan Nackaerts; Pierre Bartsch; Jacques Prignot; Sophie Marbaix
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

6.  Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers.

Authors:  Paul Howard; Christopher Knight; Annabel Boler; Christine Baker
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 7.  Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Authors:  Gillian M Keating; Katherine A Lyseng-Williamson
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

8.  Protocol for the smoking, nicotine and pregnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy.

Authors:  Tim Coleman; Jim Thornton; John Britton; Sarah Lewis; Kim Watts; Michael W H Coughtrie; Clare Mannion; Neil Marlow; Christine Godfrey
Journal:  BMC Health Serv Res       Date:  2007-01-03       Impact factor: 2.655

9.  The Quit Benefits Model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking.

Authors:  Susan F Hurley; Jane P Matthews
Journal:  Cost Eff Resour Alloc       Date:  2007-01-23

10.  Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation.

Authors:  Lieven Annemans; Sophie Marbaix; Kristiaan Nackaerts; Pierre Bartsch
Journal:  Prev Med Rep       Date:  2015-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.